Results 211 to 220 of about 1,609,728 (258)

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand   +5 more
wiley   +1 more source

Editorial: Systems Immunology and Translational Research in Infectious Diseases. [PDF]

open access: yesFront Immunol
Araújo-Pereira M   +3 more
europepmc   +1 more source

Burden of infectious diseases in children during the first year after solid organ transplantation. [PDF]

open access: yesTranspl Int
Rock NM   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy